Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
979
datasets available to search
ShareScore release 0.9.0
Dataset results
979 results for “HR”
The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer Patient With Standard Neoadjuvant Therapy in Real World.
ClinicalTrials.gov study NCT05263570. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Interview of Patients With HR+/HER2- Metastatic Breast Cancer Who Received Capivasertib + Fulvestrant
ClinicalTrials.gov study NCT07008963. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Chidamide Plus Endocrine in Maintenance Treatment of HR+/HER2- Breast Cancer After First-line Chemotherapy
ClinicalTrials.gov study NCT05890287. IPD Sharing: NO. Countries: 1. Publications: 0.
Study Evaluating Abemaciclib + Aromatase Inhibitors in HR+, HER2- Advanced Breast Cancer Patients (HERMIONE-7)
ClinicalTrials.gov study NCT04227327. IPD Sharing: NO. Countries: 1. Publications: 0.
24-hr Intraocular Pressure (IOP) Patterns of Glaucoma Patients After Selective Laser Trabeculoplasty (SLT)
ClinicalTrials.gov study NCT01495312. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Maintenance Hormone Therapy for Postmenopausal HR Positive Advanced Breast Cancer
ClinicalTrials.gov study NCT02000193. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Stereotactic Radiation & Abemaciclib in the Management of HR+/HER2- Breast Cancer Brain Metastases
ClinicalTrials.gov study NCT04923542. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
ClinicalTrials.gov study NCT06757634. IPD Sharing: UNDECIDED. Countries: 22. Publications: 0.
Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitors
ClinicalTrials.gov study NCT06929325. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02
ClinicalTrials.gov study NCT05205200. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease
ClinicalTrials.gov study NCT06760637. IPD Sharing: YES. Countries: 31. Publications: 0.
A Study of GB491 in Combination With Letrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
ClinicalTrials.gov study NCT05851014. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant SHR-A1811 Plus Adebrelimab in HR Negative/Low & HER2 Low Breast Cancer Patients
ClinicalTrials.gov study NCT06592625. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders
ClinicalTrials.gov study NCT04123483. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Endocrine Therapy +/- the PI3K Inhibitor Inavolisib in HER2+, HR+, PIK3CA Mutant Early Breast Cancer
ClinicalTrials.gov study NCT05306041. IPD Sharing: NO. Countries: 2. Publications: 0.
Adjuvant Metronomic Capecitabine Plus Endocrine Therapy for HR+/HER2- Primary Breast Cancer
ClinicalTrials.gov study NCT05063136. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer
ClinicalTrials.gov study NCT07317778. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer
ClinicalTrials.gov study NCT06447623. IPD Sharing: NO. Countries: 1. Publications: 0.
RNASeq -/+ UV 8 and 24 hr
GEO Series GSE92239. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
RUNX1-PDGFBB-AKT pathway mediated CDK4/6 inhibitor resistance in HR+/HER2- breast cancer
GEO Series GSE264264. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.